For the past five days, millions of Nigerians have been left in the dark as a nationwide power outage continues to cripple ...

We expect Teradyne to maintain a strong balance sheet and continue generating robust free cash flow while keeping minimal to no leverage. As of Dec. 31, 2024, Teradyne held a net cash position, with ...

AskBio has dosed the first participant in the second group of a Phase 1/2 trial of AB-1003, an experimental gene therapy for ...

The company is founded by Adarsh Srivastava from IIT Kanpur and Balasubramanian from IIT Bombay. CtrlB positions itself as a unified data lake for IT & Security (SIEM) data, allowing companies to ...

The expectation of MOVEM's possible synergies has become a reality. Three companies give their views on the future of the ...

Arm’s low-end edge-computing solution combines the Cortex-M85 with an Ethos-U85 neural processing unit (NPU). The platform ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional ...

Explore Eve Holding's Q4 2024 earnings call highlights, featuring eVTOL milestones, $429M liquidity, $14B pre-order backlog, and 2027 certification goals.

Fzata, Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a Phase 1 clinical trial of FZ002 for C. difficile treatment. Oral FZ002 is a ...

Synvect, Inc., a biotechnology startup pioneering next-generation vector control solutions, has raised a $3M Seed Round from ...

Eve Holding, Inc. ("Eve") (NYSE: EVEX and EVEXW) reports its fourth quarter and fiscal year 2024 earnings results. Year ...

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with potentially increased effectiveness and safety for the treatment for ...